Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi, Yaser A. Mostafa, Mostafa Abdelrahman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 22

Showing 22 citing articles:

Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 10
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
Abubakar Ahmed, Anber F. Mohammed, Zainab M. Almarhoon, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access
A Concise Review on Recent Development of Indole Derivatives for Anticancer Activities
B. T. Sridhar, Nagesh Gunavanthrao Yernale, Ramesh S. Gani, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101282-101282
Closed Access | Times Cited: 4
Synthesis and SARs study of novel spiro‐oxindoles as potent antiproliferative agents with CDK‐2 inhibitory activities
Refaah Mousa Al‐Jassas, Mohammad Shahidul Islam, Abdullah Mohammed Al‐Majid, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 8
Closed Access | Times Cited: 13
Synthesis, in-silico studies, and biological evaluation of some novel 3-thiazolyl-indoles as CDK2–inhibitors
Sobhi M. Gomha, Magdi E. A. Zaki, Deepika Maliwal, et al.
Results in Chemistry (2023) Vol. 6, pp. 101209-101209
Open Access | Times Cited: 11
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8
New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors
Yaser A. Mostafa, Abdeljalil Assoud, Ahmed Desoky, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAFV600E Dual Inhibitors Endowed with Antiproliferative Activity
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Alaa A. Hassan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1014-1014
Open Access | Times Cited: 7
Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action
Fatma A. Mohamed, Saleha Y. M. Alakilli, Eman Fawzy El Azab, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 4, pp. 734-744
Closed Access | Times Cited: 6
Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1039-1039
Open Access | Times Cited: 6
Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl)quinolin-2(1H)-ones as Multi-Target Inhibitors
Essmat M. El‐Sheref, Stefan Bräse, Hendawy N. Tawfeek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13300-13300
Open Access | Times Cited: 6
Anticancer Evaluation of Novel Benzofuran–Indole Hybrids as Epidermal Growth Factor Receptor Inhibitors against Non-Small-Cell Lung Cancer Cells
Yechan Lee, Sun Hee Lee, Younho Lee, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 231-231
Open Access | Times Cited: 1
Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Recent Development in the Search for Epidermal Growth Factor Receptor (EGFR) Inhibitors based on the Indole Pharmacophore
Shweta Mishra, Adarsh Sahu, Avneet Kaur, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 24, Iss. 7, pp. 581-613
Closed Access | Times Cited: 3
Pyrrolizine/indolizine-bearing (un)substituted isoindole moiety: design, synthesis, antiproliferative and MDR reversal activities, and in silico studies
Amr L. AbdelSamad, Mohammed T. El‐Saadi, Ahmed M. Gouda, et al.
RSC Advances (2023) Vol. 13, Iss. 44, pp. 30753-30770
Open Access | Times Cited: 2
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access
Inhibitors and PROTACs of CDK2: challenges and opportunities
Yangjie Zeng, Xiaodong Ren, Pengyao Jin, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1125-1148
Closed Access
Design, synthesis, and biological evaluation of novel quinoline-based EGFR/HER-2 dual-target inhibitors as potential anti-tumor agents
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Hendawy N. Tawfeek, et al.
RSC Advances (2024) Vol. 14, Iss. 45, pp. 32978-32991
Open Access
Integrating network pharmacology and pharmacological evaluation to investigate the anticancer effects of Duranta erecta Linn. Verbenaceae in breast cancer
Yannick Luther Agbana, Thomas Abu, Toluwanimi E. Akinleye, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Special Issue “Novel Anti-Proliferative Agents”
Valentina Onnis
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1437-1437
Open Access
New pyrrolidine‐carboxamide derivatives as dual antiproliferative EGFR/CDK2 inhibitors
Frias Obaid Arhema Frejat, Bing Zhao, Nooruldeen Furaijit, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access
Page 1

Scroll to top